Tizanidine Hydrochloride Capsule
Product Images NDC 72789-507

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 72789-507). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789507 Label (72789507)

Label for tizanidine hydrochloride 4 mg capsules by PD-Rx Pharmaceuticals, Inc. The label states each capsule contains 4.58 mg tizanidine hydrochloride equivalent to 4 mg tizanidine base, with a package size of 150 capsules. It includes storage instructions, barcode, manufacturer information, and a warning that the product is not interchangeable with tizanidine tablets or Zanaflex tablets.*

FDA Label Image

Figure 1 (Tizanidine Hydrochloride Capsules Figure 1)

A line graph showing plasma tizanidine concentration (ng/mL) over time (hours) after dosing. It compares the concentration profiles of 4 mg tizanidine tablets and capsules taken with and without food, over a period of 24 hours.*

FDA Label Image

Figure 2 (Tizanidine Hydrochloride Capsules Figure 2)

A line graph illustrating the improvement in Ashworth Score over a 6-hour post-dose period comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis measures improvement in Ashworth Score, with higher values indicating more improvement. The horizontal axis shows hours post-dose from 0 to 6. Error bars represent variability in the data points for each treatment group over time.*

FDA Label Image

Figure 3 (Tizanidine Hydrochloride Capsules Figure 3)

A line chart comparing improvement in Ashworth Score over time between tizanidine (mean dose 28.8 mg) and placebo. The x-axis shows time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The y-axis represents improvement in Ashworth Score, ranging from -6 to 2. Tizanidine data shows greater improvement with higher negative scores, with error bars at each time point, compared to placebo which shows smaller changes near zero.*

FDA Label Image

Chemical Structural Formula (Tizanidine Hydrochloride Capsules Structure)

Chemical structure of tizanidine hydrochloride, showing the molecular arrangement with chlorine, nitrogen, sulfur atoms, and the hydrochloride, relevant to the active ingredient tizanidine hydrochloride in the product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.